Castle Biosciences CSTL
NASDAQ CSTL
$34.37 +1.22 (+3.68%)
At close: Oct 21, 2026 · 4:00 PM EDT

Castle Biosciences (CSTL) EV to EBITDA (2019 - 2025)

Updated

Castle Biosciences' (CSTL) EV to EBITDA came in at 48.08 for Q3 2025, up 15.2% from 41.73 a year earlier and up 195.9% from the prior quarter.

Analysis

Castle Biosciences (CSTL) EV to EBITDA (2019 - 2025) Analysis & Trends

For the trailing twelve months through Sep 30, 2025, EV to EBITDA at Castle Biosciences was -59.76; for FY2024, it was 18.89.

  • The Q3 2025 figure stands as the highest quarterly EV to EBITDA since Q2 2020.
  • According to Business Quant data, EV to EBITDA for the three prior quarters was 16.25 (Q2 2025), 10.56 (Q1 2025) and 18.89 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 101.22 Bn 97.23 Bn -
2 Natera 59.29 Bn 54.98 Bn 485.19 Mn
3 Quest Diagnostics 26.56 Bn 24.69 Bn 1.03 Bn
4 Labcorp Holdings 26.41 Bn 24.16 Bn 1.11 Bn
5 Tenet Healthcare 22.49 Bn 11.49 Bn -
6 Guardant Health 22.12 Bn 18.19 Bn 219.03 Mn
7 BrightSpring Health Services 12.91 Bn 11.24 Bn 492.75 Mn
8 Fresenius Medical Care AG 12.56 Bn 4.51 Bn 1.52 Bn
9 Tempus AI 12.17 Bn 9.20 Bn 246.50 Mn
10 Castle Biosciences 1.05 Bn -67.48 Mn 79.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 48.08
Jun 30, 2025 16.25
Mar 31, 2025 10.56
Dec 31, 2024 18.89
Sep 30, 2024 41.73
Sep 30, 2020 2,019.03
Jun 30, 2020 61.54
Mar 31, 2020 38.10
Dec 31, 2019 20.41
Sep 30, 2019 11.70
API Access

Castle Biosciences EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CSTL&period=max&api_key=YOUR_API_KEY